Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Type 2 Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Federico II University of Naples, Department of Advanced Biomedical Sciences

Naples, Napoli, 80131, Italy

Location status: Recruiting

Location contact

Pasquale Perrone Filardi

CONTACT

[email protected]

+39081/7462224

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age ≥ 18 years;
Diagnosis of type 2 diabetes mellitus (T2DM);
Stable clinical conditions
Outpatient settings
Ability to understand the study procedures and provide written informed consent.

Exclusion criteria

Patients with type 1 diabetes mellitus;
Active participation in interventional studies;
Any condition that may put the patient at risk by participating in the study.

Treatment and study plan

Data Collection

Other

Data collection on diabetes therapy and follow-up

Primary outcomes

Diabetes treatment adherence according to the most recent European Guidelines

Time frame: 12-24-36-48 months

Outpatients clinic treatment adherence will be measured as the percentage of patients receiving guideline-directed medical therapy prescriptions.

Study contacts

Contact information is provided by the study sponsor or research team.

Pasquale Perrone Filardi

CONTACT

[email protected]

+39081/746224

Sponsors and collaborators

Lead sponsor

Federico II University

Other

Registry information

Official study title

Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy - CardioMET Registry

Acronym: CardioMET

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2027
First posted: Jan 29, 2026
Registry last updated: Mar 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting